← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2015Last known activity
Aug 20, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 5 trials)
Phase 2 (4 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT06549556CollaboratorPhase 2Aug 20, 2024
- NCT06549556OfficialPhase 2Aug 20, 2024
- NCT06007430OfficialPhase 2Mar 1, 2023
- NCT04041856Reponsible party - principal investigatorPhase 1/Phase 2Aug 23, 2019
- NCT04041856Lead sponsorPhase 1/Phase 2Aug 23, 2019
- NCT02663141CollaboratorPhase 2Jun 1, 2015
- NCT03138785Lead sponsorN/AJan 1, 2015
- NCT03138785Reponsible party - principal investigatorN/AJan 1, 2015
Details
- Last known activity
- Aug 20, 2024